This indicates that Treg cells may mitigate the cascade and amplified response of intestinal inflammation by regulating the release of IL-10, TGF-β, and other anti-inflammatory factors, thus leading to an improvement in the clinical symptoms of IBD (38, 39). Here, TGFB1 is linked to inflammatory bowel disease.